<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04668391</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-2020-350</org_study_id>
    <nct_id>NCT04668391</nct_id>
  </id_info>
  <brief_title>Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery</brief_title>
  <official_title>Ultrasound-guided Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Cancer Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, controlled, noninferiority trial for evaluating the&#xD;
      efficacy of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate&#xD;
      ligament versus thoracic epidural analgesia after open liver surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 17, 2020</start_date>
  <completion_date type="Actual">July 2, 2021</completion_date>
  <primary_completion_date type="Actual">June 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS (numeric rating scale) score for coughing pain</measure>
    <time_frame>at 24 hours after surgery</time_frame>
    <description>Postoperative pain was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NRS score for rest and coughing pain</measure>
    <time_frame>at 1, 6, 24, 48, 72 hours after surgery</time_frame>
    <description>Postoperative pain at rest and during coughing was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>consumption of opioid converted to IV morphine equivalents</measure>
    <time_frame>during 24 hours after surgery</time_frame>
    <description>opioids given postoperatively converted to IV morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numbers of additional analgesics</measure>
    <time_frame>during 72 hours after surgery</time_frame>
    <description>Additional rescue analgesics were used when pain relief was inadequate (NRS &gt;3). The choice of rescue analgesic was oxydone 5-10mg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of postoperative hypotension</measure>
    <time_frame>during 72 hours after surgery</time_frame>
    <description>Adverse reactions related to analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of nausea and vomiting</measure>
    <time_frame>during 72 hours after surgery</time_frame>
    <description>Adverse reactions related to analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of pruritus</measure>
    <time_frame>during 72 hours after surgery</time_frame>
    <description>Adverse reactions related to analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of respiratory depression</measure>
    <time_frame>during 72 hours after surgery</time_frame>
    <description>Adverse reactions related to analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to ambulation in days</measure>
    <time_frame>through study completion, an average of 2-3 days</time_frame>
    <description>Postoperative ambulation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to eat in days</measure>
    <time_frame>through study completion, an average of 2-3 days</time_frame>
    <description>Time to start eating after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to flatus in hours</measure>
    <time_frame>through study completion, an average of 40-50 hours</time_frame>
    <description>Time to flatus after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to defecation in hours</measure>
    <time_frame>through study completion, an average of 60-70 hours</time_frame>
    <description>Time to defecation after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to urethral catheter removal in hours</measure>
    <time_frame>through study completion, an average of 60-70 hours</time_frame>
    <description>Time tourethral catheter removal after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay in days</measure>
    <time_frame>through study completion, an average of 7-8 days</time_frame>
    <description>The time from operation to discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clavien-Dindo classification (grade I, II, III, IV) for postoperative complication</measure>
    <time_frame>One month after surgery</time_frame>
    <description>Postoperative Clavien-Dindo complication classification</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Liver Surgery</condition>
  <arm_group>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thoracic epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic epidural analgesia at the level of T7-10.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament</intervention_name>
    <description>Bilateral single-injection 20 ml 0.56% ropivacaine. Intravenous analgesia was started postoperatively and consisted of 1ug/ml sufentanil，2 ml/h with a 5-minute lockout period, a limited 12 ml/h dose.</description>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic epidural analgesia</intervention_name>
    <description>A thoracic epidural at the level of T7-10. Epidural infusion was started postoperatively and consisted of sufentanil (0.6ug/mL) and ropivacaine（0.2%） at 3ml/h.</description>
    <arm_group_label>Thoracic epidural analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age≥18 years&#xD;
&#xD;
          -  ASA I-III&#xD;
&#xD;
          -  Open liver surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to nerve block or epidural puncture&#xD;
&#xD;
          -  Chronic use of opioids or NSAIDs&#xD;
&#xD;
          -  Refused to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huifang Jiang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhejiang Caner Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Li H, Ma D, Liu Y, Wang Y. A transverse approach for ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament. Anaesthesia. 2020 Oct;75(10):1400-1401. doi: 10.1111/anae.15058. Epub 2020 Jun 24.</citation>
    <PMID>32578192</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 13, 2020</study_first_submitted>
  <study_first_submitted_qc>December 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>October 24, 2021</last_update_submitted>
  <last_update_submitted_qc>October 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

